Dexcom is a medical device company primarily focused on the design, development, and commercialization of continuous glucose monitoring (CGM) systems. These CGMs are used by people with insulin intensive diabetes. Insulin intensive diabetes requires active management of blood glucose levels to avoid adverse affects such shaking, sweating, and in the most extreme cases seizures and loss of consciousness. The G5 Mobile CGM system is a capable of giving people with intensive diabetes state of the art technology to control the blood glucose level and maintain it to be within a specified range.
Embramsyah, Agam; Razavi, Asma; Reyes, Catalina; Miller, Cody; Perreira, William; and Asafo-Adjei, Charles, "G5 Mobile Marketing Plan" (2017). Engineering and Technology Management Student Projects. 147.